Your browser doesn't support javascript.
loading
The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.
Tosco, L; Laenen, A; Briganti, A; Gontero, P; Karnes, R J; Albersen, M; Bastian, P J; Chlosta, P; Claessens, F; Chun, F K; Everaerts, W; Gratzke, C; Graefen, M; Kneitz, B; Marchioro, G; Salas, R S; Tombal, B; Van den Broeck, T; Moris, L; Battaglia, A; van der Poel, H; Walz, J; Bossi, A; De Meerleer, G; Haustermans, K; Van Poppel, H; Spahn, M; Joniau, S.
Afiliação
  • Tosco L; Department of Development and Regeneration, University Hospitals Leuven, Urology, Leuven, Belgium.
  • Laenen A; Department of Imaging and Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven, Leuven, Belgium.
  • Briganti A; Department of Public Health and Primary Care, Leuven Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Belgium.
  • Gontero P; Department of Urology, San Raffaele Hospital, University VitaSalute, Milan, Italy.
  • Karnes RJ; Department of University Urology, Urologia U, Città della Salue e della Scienza di Torino, Molinette Hospital, Turin, Italy.
  • Albersen M; Department of Urology, Mayo Clinic, Rochester, MN, USA.
  • Bastian PJ; Department of Development and Regeneration, University Hospitals Leuven, Urology, Leuven, Belgium.
  • Chlosta P; Department of Urology, Urologische Klinik Und Poliklinik, Klinikum Der Universität München Campus Großhadern, Munich, Germany.
  • Claessens F; Department of Urology, Jagiellonian University Medical College, Krakow, Poland.
  • Chun FK; Department of Cellular and Molecular Medicine, Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.
  • Everaerts W; Department of Urology, University of Hamburg, Hamburg, Germany.
  • Gratzke C; Department of Development and Regeneration, University Hospitals Leuven, Urology, Leuven, Belgium.
  • Graefen M; Department of Urology, Urologische Klinik Und Poliklinik, Klinikum Der Universität München Campus Großhadern, Munich, Germany.
  • Kneitz B; Department of Urology, Martini Klinik am UKE GmbH, Hamburg, Germany.
  • Marchioro G; Department of Urology and Pediatric Urology, University Hospital Wurzburg, Wurzburg, Germany.
  • Salas RS; Department of Urology, University of Piemonte Orientale, Novara, Italy.
  • Tombal B; Department of Urology, Institut Mutualiste Montsouris and Paris Descartes University, Paris, France.
  • Van den Broeck T; Department of Urology, Cliniques Universitaires SaintLuc, Brussels, Belgium.
  • Moris L; Department of Cellular and Molecular Medicine, Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.
  • Battaglia A; Department of Cellular and Molecular Medicine, Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.
  • van der Poel H; Department of University Urology, Urologia U, Città della Salue e della Scienza di Torino, Molinette Hospital, Turin, Italy.
  • Walz J; Department Of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Bossi A; Department of Urology, Institut Paoli Calmettes Cancer Centre, Marseille, France.
  • De Meerleer G; Department of Radiation Oncology, Gustave Roussy Cancer Institute, Villejuif, France.
  • Haustermans K; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Van Poppel H; Department of Radiation Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Spahn M; Department of Development and Regeneration, University Hospitals Leuven, Urology, Leuven, Belgium.
  • Joniau S; Department of Urology, University Hospital Bern, Inselspital, Berne, Switzerland.
Prostate Cancer Prostatic Dis ; 20(4): 407-412, 2017 12.
Article em En | MEDLINE | ID: mdl-28485390
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antineoplásicos Hormonais / Antagonistas de Androgênios Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Antineoplásicos Hormonais / Antagonistas de Androgênios Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: Prostate Cancer Prostatic Dis Assunto da revista: ENDOCRINOLOGIA / NEOPLASIAS / UROLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica